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RLETTER TO THE EDITOR
Can cardiac magnetic resonance imaging
resolve cardiac and neurological enigmas
of left ventricular
hypertrabeculation/non-compaction?
Est-ce que l’IRM peut résoudre les énigmes
cardioneurologiques d’un VG non compacté ?
Keywords: Echocardiography ; Magnetic resonance imag-
ing ; Cardiomyopathy
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With interest, we read the article by Thuny et al.
about the side-by-side comparison of cardiac mag-
netic resonance imaging (CMRI) and echocardiography in
16 patients with echocardiographically suspected left ven-
tricular hypertrabeculation/non-compaction (LVHT) [1]. We
have the following questions.
Echocardiographic data indicate that LVHT may be over-
diagnosed in black Africans [2]. Were there any black
Africans among the included patients, and did the morphol-
ogy and distribution of LVHT differ between Africans and
Caucasians?
The authors stated that none of the patients had signs
or symptoms of a neuromuscular disease. Were they investi-
gated neurologically, and if so, by which means? Since LVHT
is frequently associated with neuromuscular disease, when
systematically screened, it would be interesting to compare
CMRI ﬁndings in patients with and without neuromuscular
disease [3].
According to Table 1, ﬁve patients had a family history
of LVHT. Were any of these relatives included among the
ﬁve study patients? If so, were the pattern and distribution
of LVHT different or similar in the relatives? LVHT is fre-
quently associated with genetic disorders. Were the patients
screened for mutations in genes reported to be associated
with LVHT [4]?
LVHT frequently is associated with ventricular arrhyth-
mias, systolic dysfunction and thromboembolic events. Did
any of the 16 patients experience a stroke or peripheral
embolism? How many of the patients received oral anticoag-
ulation, and how many received pharmacotherapy for heart
failure or rhythm abnormalities?
[
1875-2136/$ — see front matter © 2010 Elsevier Masson SAS. All rights re
doi:10.1016/j.acvd.2010.07.003Can you provide an explanation for the discrepancy
etween left ventricular ejection fraction assessed by
chocardiography and CMRI, especially in patients 1, 3, 5
nd 15, in whom the discrepancy exceeded 10%? How did
he observers differentiate LVHT from papillary muscles and
berrant bands, which might pretend to be LVHT, especially
n the short-axis views and in the basal myocardial segments?
t is indicated that only the maximal ratio between non-
ompacted and compacted myocardial layer was used for
he analysis. Did the echocardiographic and CMRI observers
gree on the segment where the maximal ratio was mea-
ured?
In three patients, pathological analysis of the hearts was
erformed, but the ﬁndings of this analysis and the compar-
son with echocardiography and CMRI were not presented.
ince there is a lack of data correlating patho-anatomy with
maging ﬁndings in LVHT, it would be interesting to see these
esults.
LVHT may develop during the course of an individual’s
ife, as well as disappear, and an undulating pattern has been
escribed in children [5,6]. Was it possible to analyse previ-
us echocardiographic or CMRI recordings in order to assess
hether LVHT developed or changed over time? Did the
uthors perform any follow-up investigations of the included
atients and did they observe changes in LVHT? Since CMRI
elineates the extent of LVHT better than echocardiography,
t might also diagnose LVHT more accurately in those cases,
n which echocardiography is uncertain or the diagnostic
riteria are not completely fulﬁlled.
As reported previously, the study conﬁrms that the sep-
al segments are only rarely affected by LVHT [7]. Can you
rovide any explanation for these ﬁndings?
In conclusion, from this well-documented series of
atients with LVHT, still more information and data should
e obtained, which could contribute to the clariﬁcation of
ome of the enigmas of LVHT.
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